Boralex (OTCMKTS:BRLXF) PT Raised to C$47.00 at Desjardins

Boralex (OTCMKTS:BRLXFGet Rating) had its target price hoisted by research analysts at Desjardins from C$46.00 to C$47.00 in a note issued to investors on Thursday, The Fly reports.

Other analysts have also issued reports about the company. Credit Suisse Group raised Boralex from a “neutral” rating to an “outperform” rating in a research note on Monday, January 24th. Scotiabank cut their price target on Boralex from C$45.25 to C$42.75 in a research note on Thursday, February 24th. CIBC cut their price target on Boralex from C$48.00 to C$42.00 in a research note on Tuesday, January 11th. National Bank Financial lifted their price objective on Boralex from C$44.00 to C$48.00 in a research note on Monday, April 11th. Finally, TD Securities lifted their price objective on Boralex from C$46.00 to C$50.00 in a research note on Wednesday, March 2nd. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of $45.39.

Shares of BRLXF stock opened at $30.79 on Thursday. The business’s 50-day moving average price is $30.10 and its 200-day moving average price is $28.58. Boralex has a 12 month low of $24.08 and a 12 month high of $34.63.

Boralex Company Profile (Get Rating)

Boralex Inc, together with its subsidiaries, engages in the development, construction, and operation of renewable energy power facilities primarily in Canada, France, and the United States. As of December 31, 2021, the company had interests in 90 wind power stations with an installed capacity of 2,032 megawatts (MW); 16 hydroelectric power stations with a capacity of 181 MW; 12 solar power stations with an installed capacity of 244 MW; and one thermal power station with an installed capacity of 35 MW.

Read More

The Fly logo

Analyst Recommendations for Boralex (OTCMKTS:BRLXF)

Receive News & Ratings for Boralex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boralex and related companies with MarketBeat.com's FREE daily email newsletter.